Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Background: Substitution of methionine for threonine at codon 790 (T790M) of epidermal growth factor receptor (EGFR) represents the major mechanism of resistance to EGFR tyrosine kinase inhibitors (TKIs) in EGFR -mutant non-small-cell lung cancer. We determined the prognostic impact and association...

Descrición completa

Detalles Bibliográficos
Main Authors: Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, Jia-Shiuan Ju, Chi-Hsien Huang, Chin-Chou Wang, How-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
Formato: Artigo
Idioma:English
Publicado: SAGE Publishing 2024-01-01
Series:Therapeutic Advances in Medical Oncology
Acceso en liña:https://doi.org/10.1177/17588359231222604

Internet

https://doi.org/10.1177/17588359231222604

Títulos similares